Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

alpha Galactosidase Chicken anti-Human, Polyclonal, Invitrogen™

Chicken Polyclonal Antibody

Manufacturer:  Invitrogen PA19528

Catalog No. 01-674-411


Add to cart

Description

Description

PA1-9528 detects Alpha Galactosidase in human samples. PA1-9528 has been successfully used in Western blot and ELISA procedures. The PA1-9528 immunogen is a mix of synthetic peptides corresponding to residues 55-64 and 396-407 of human alpha Galactosidase. Store at 4°C for one week, and -20°C for long term storage.

This gene encodes a homodimeric glycoprotein that hydrolyses the terminal alpha-galactosyl moieties from glycolipids and glycoproteins. This enzyme predomitly hydrolyzes ceramide trihexoside, and it can catalyze the hydrolysis of melibiose into galactose and glucose. A variety of mutations in this gene affect the synthesis, processing, and stability of this enzyme, which causes Fabry disease, a rare lysosomal storage disorder that results from a failure to catabolize alpha-D-galactosyl glycolipid moieties.
Specifications

Specifications

alpha Galactosidase
Polyclonal
Unconjugated
GLA
Liquid
GLA
Mix of synthetic peptides corresponding to residues 55-64 and 396-407 of human alpha Galactosidase
IgY fraction
RUO
Antibody
Polyclonal
Human
ELISA, Western Blot
1 mg/mL
PBS with 0.02% sodium azide
P06280
GLA
Chicken
IgY
500 μg
-20° C, Avoid Freeze/Thaw Cycles
Primary
2717
Documents
Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit